Industry: Healthcare providers & services
Walgreens settles covid testing dispute
US pharmacy chain Walgreens has agreed to pay US$595 million to a telemedicine group to settle a dispute over covid-19 testing.
26 February 2025
Novo Nordisk to bring fraud claim over hypertension drug
Danish pharmaceutical group Novo Nordisk is preparing to launch an ICC arbitration worth US$830 million against a Singapore biosciences company for alleged fraud, after acquiring a hypertension drug that failed in clinical trials.
19 February 2025
Walgreens fails to set-aside billion-dollar award over covid-19 tests
A US court has refused to set aside an award ordering US pharmacy chain Walgreens to pay US$988 million in a dispute over covid-19 testing, rejecting allegations the sole arbitrator was biased and ignored a liability cap.
13 February 2025
Indian healthcare provider drops bid to thwart sale of hospital network
A Mumbai healthcare provider has discontinued an ad hoc arbitration in which it had sought to block the sale of a hospital network to a rival US bidder – after failing to secure interim relief.
20 May 2024
US healthcare group wins damages in Indian M&A dispute
A US digital health services provider has won an ICC award worth over US$110 million against the sellers of an Indian healthcare business over their refusal to relinquish control of the company after the sale.
26 March 2024
Czech Republic has limited success in challenge to plasma award
A UK court has upheld one of the Czech Republic’s grounds of challenge to a US$730 million treaty award won by investors in a blood plasma business, while dismissing or reserving judgment on other objections.
08 March 2024
Indian arbitrator refuses to restrain sale of hospital network
An Indian arbitrator has refused a Mumbai healthcare provider’s request for interim measures to restrain a US private equity firm from selling a hospital network to rival bidders.
18 August 2023
Czech Republic challenges plasma award
The Czech Republic has applied to annul a US$650 million treaty award holding it liable for frustrating the investment of a blood plasma supplier and its owner, including through the state's actions in an earlier contractual arbitration, while revealing the investors had sought up to US$2.2 billion.
17 June 2022
LCIA award upheld in med-tech dispute
A UK judge has rejected a German healthcare equipment supplier’s bid to revive a €575 million LCIA claim, dismissing arguments that the arbitrators ignored the undisputed evidence of their own witness.
14 April 2022
WATCH: GAR Connect Moscow Workshop
A full recording of our GAR Connect Moscow Workshop can be found here.
14 May 2021